Condensed Consolidated Statements of Changes in Equity (Unaudited) (USD $)	Series B Preferred Stock	Common Stock	Additional Paid-In Capital	Accumulated Deficit	Accumulated Other Comprehensive Income (Loss)	Noncontrolling Interest
Beginning Balance Amount at Jun. 30, 2013		$ 885,389	$ 85,464,055	$ (80,932,824)	$ (1,594,418)	$ 2,304,121
Beginning Balance Shares at Jun. 30, 2013		17,707,431
Net income (loss)				(8,855,418)		(657,881)
Net currency translation adjustment					(5,457)
Issuance of warrants			498,793
Issuance of common stock, net of costs and underwriting fees, Shares		6,325,000
Issuance of common stock, net of costs and underwriting fees, Amount		63,250	12,973,214
Issuance of preferred stock, net of costs and underwriting fees, Shares	3,000
Issuance of preferred stock, net of costs and underwriting fees, Amount	30		2,388,756
Issuance of warrants to underwriter			15,455
Stock-based compensation, Shares		245,570
Stock-based compensation, Amount		2,456	959,905
Conversion of preferred stock, Shares	(425)	470,171
Conversion of preferred stock, Amount	(4)	4,701	(4,696)
Exercise of warrants, Shares		903,217
Exercise of warrants, Amount		9,032	(9,032)
Ending Balance Amount at Jun. 30, 2014	26	964,828	102,286,450	(89,788,242)	(1,599,875)	1,646,240
Ending Balance Shares at Jun. 30, 2014	2,575	25,651,389
Net income (loss)				(2,640,349)		399,368
Net currency translation adjustment					4,170
Issuance of common stock, net of costs and underwriting fees, Shares		13,248,000
Issuance of common stock, net of costs and underwriting fees, Amount		132,480	13,557,257
Stock-based compensation, Shares		145,570
Stock-based compensation, Amount		1,456	374,936
Contribution of capital from noncontrolling interest						7,127
Ending Balance Amount at Sep. 30, 2014	$ 26	$ 1,098,764	$ 116,218,643	$ (92,428,591)	$ (1,595,705)	$ 2,052,735
Ending Balance Shares at Sep. 30, 2014	2,575	39,044,959